尼日利亚最大制药企业Fidson Healthcare Plc宣布将携手中国公司，在西非国家内启动一座价值10亿美元的药物生产厂建设工作，旨在缓解该地区的药品短缺问题。
近日，Fidson与中企以及中国-非洲发展基金签署合作协议，计划在未来30个月内开始在尼日利亚商业中心拉各斯兴建工厂。此举是为了促进“医疗卫生领域的自给自足”，特别是针对打击艾滋病的行动。据统计，作为非洲人口最多的国家，尼日利亚约有200万人感染了艾滋病病毒。
然而，该国去年报告每周新发1400例感染者，并且大约有120万儿童因此成为孤儿。与此同时，随着高通货膨胀、汇率波动、频繁的安全威胁以及电力短缺等问题，美国和欧洲的大公司正纷纷从尼日利亚撤离，包括跨国企业GSK等，这导致了对艾滋病机会性感染药物的获取变得更困难。
Fidson Healthcare作为曾经生产非处方药的重要企业，在国内的药品供应链中扮演着重要角色。自去年6月以来，该公司已推出了超过16款新产品。
“通过整合我们在创新药物领域的专长和经验，我们有信心为患者带来更大的福祉。”Fidson表示，“所有合作伙伴的互补能力将为医疗行业注入新的活力。”
请关注我们的“Next Africa”双周电子通讯，获取最新从非洲大陆传来的商业与经济新闻。
新闻来源：www.bloomberg.com
原文地址：China, Nigeria Drugmakers Plan to Build Plant in African Nation
新闻日期：2024-09-27
原文摘要：
Nigeria’s biggest drugmaker will partner with Chinese firms to build a $100 million plant in the West African nation to help alleviate a shortage of medicines. Fidson Healthcare Plc signed a cooperation memorandum with , and the China-Africa Development Fund to start building the facility in the commercial capital of Lagos within the next 30 months, the Nigerian drugmaker said by email.The plant aims to foster “self-reliance in health-care delivery, especially to tackle HIV” in Nigeria, Fidson said. Africa’s most populous nation has an estimated 2 million people living with the virus, according to the . Last year, the government’s National Agency for the Control of AIDS said the country recorded about 1,400 new infections weekly, and about 1.2 million children are orphaned because of it.You can follow Bloomberg’s reporting on Africa on WhatsApp. The country of 220 million people imports all its anti-retroviral drugs, limiting availability. Surging inflation, a volatile and depreciating currency, rampant insecurity and electricity shortages are driving US and European multinationals out of Nigeria, including and , worsening access to medications for opportunistic infections arising from the disease.Fidson, which manufactured over-the-counter drugs for GSK, is stepping in to fill the void in the country’s drug-supply chain. It has introduced more than 16 new products since June last year, according to the company. Read more: “By integrating our expertise and experience in the field of innovative drugs, we are confident in bringing greater well-being to patients,” Fidson said. “The complementary strengths of all parties will inject new vitality into the health-care sector.” for the twice-weekly Next Africa newsletter for the latest business and economic news from the continent.
